Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models
Jin et al develop and characterise a blood-brain barrier and plasma membrane-permeable α-synuclein knockdown peptide, Tat-βsyn-degron. In two mouse models of Parkinson’s disease, they show that Tat-βsyn-degron decreases α-synuclein aggregates and microglial activation as well as reducing neuronal da...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/63d676340fd343489fc159532b920ece |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|